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CHAPTER I 
INTRODUCTION 
Anaplasmosis is an infectious disease of animals of the genera, 
Bos, ~' Capra and some species of Bison ___ and Cervidae. The disease 
is characterized by a rapid progressive normocytic normochromic anemia, 
In the convalescent animal the anemia becomes a macrocytic hypochromic 
anemia. As.the animal recovers, the erythrocytes subsequently return 
to normal numbers, size and hemoglobin content (1). 
Anaplasma marginale (Theileri) is the narne given to small round 
bodies, 0.5u to LOu in diameter, which are consistently found in the 
erythrocytes of animals experiencing the progressive phase of the 
anemia. 
The infective form has an average diameter of 0.30u (2), and 
eight or more subunits in a more or less spherical arrangement with 
or without variouslyshaped delicate projections, The organism's 
oxygen requirements lie somewhere between those of the virus and the 
malarial protozoan parasite ( 3),. The causative agent is transmitted 
mechanically by transfer of intact erythrocytes by fomites and by 
insects of the genera, Tabanus a:nd CulicoideiL It is biologically 
transmitted by the genus Ixoididae (1). 
Although the question of distinctly different isolates is still 
undecided, Murphy (4) reports an apparently successful cross-challenge 
1 
of a splenectomized calf infected initially with the Florida-isolate 
(or strain). He cross-challenged with a California-isolate (or 
strain). (See Appendix, Figure 46). Other workers have reported 
differences in isolates from various parts of the United States (5). 
The clinical signs and symptoms of anaplasmosis in cattle are 
those characteristic of a severe anemia. These signs and symptoms 
are usually not evident until there has been a 40 to 60 percent re-
duction in the erythrocyte packed cell volume (PCV). The onset of 
the disease is signaled by depression, weakness, anorexia and fever 
followed in two to four days by weight loss, dyspnea, diarrhea or 
constipation, rumen atony, pale mucus membranes, tachycardia, irreg-
ular heart sound and, in some cases, icterus (6). 
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It has been suggested that upon ente·ring the new host, the infec-
tive agent has a short development period in the bone marrow, after 
which it infects an increasing number of certain stages of the matur-
ing erythroid cell (1). There is a 10-20 percent reduction in bone 
marrow erythroblasts that starts about ten days prior to the appear-
ance of 1 percent infected erythrocytes.* This apparent suppression 
continues for about 6 days after the appearance of 1 percent infected 
erythrocytes (7). The infected circulating erythrocytes are rapidly 
destroyed by hemolysis, causing the typical anemic syndrome (8). The 
bilirubinglobin from the hemolized erythrocytes is converted to bili-
rubin and excreted. Icterus, when present, indicates anoxic liver 
damage and is caused by bilirubin retention. Icterus usually is seen 
*In these cases the average incubation period was 21 days. 
after the peak anemia has passed. The recovered animal, in most 
cases, remains a clinically inapparent carrier of the infectious 
agent for :Life ( 1) . 
The syndrome in cattle less than one year. ol.d. is usually mild, 
often clinic.ally undetectable. The disease is of moderate intensity 
in yearlings and two-year.:..olds... In older cattle the disease is 
usually severe and is frequently.· fatal ( 9) . 
Although anaplasmosis appears to be an acute hemolytic anemia, 
hemoglobinernia and hemoglobinuria· are not apparent (6; 8, 10). An 
autoimmune mechanism has been proposed as the mechanism of erythro-
cyte destruct.ion (11, 12). The writer has. certain reservations about 
the statistical.validity of wO'rk · done in this area,. There . are con-
flicting laboratory reports (11.,..13). Although.an autoimmune mecha-
nism has some merit, such a-mechanism would not appear to be compat-
ible with the increased susceptibility resulting from splenectomy. 
The exact mechanism of erythrocyte destruction remains undefined. 
The Spleen-(Mysterii Plenum OrganonrGalen) 
As previously mentioned, various.writers have cited the increased 
susceptibility of the bovine animal to anaplasmosis after splenectomy 
(1, 9). It has been shown that the removal of the spleen has a marked 
influence on the course of. anaplasmosis, the course of the disease 
being more severe in the splenectomized calf (4.). Splenectomy of the 
carrier calf cause a severe relapse t:o the anemic phase of the 
disease (4, 14). 
The spleen is a large gland,-like, but quctless, organ situated 
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in the upper part of the abdominal cavity on the left side. It has a 
flattened oblong shape and a pliable consistency (15). Sisson (16) 
descfibes the bovine spleen as being 50 cm~ by 15 cm. in size, weigh-
ing approximately 900 Grns. and being equal to 1/6 of one percent of 
the animal's bodyweight .. With the possible exception of the hemal 
lymph nodes, all the lymphatic tissue of the body that is specialized 
to filter blood is concentrated in the spleen (17). Recent evidence 
indicates rather conclusively that the spleen has a closed circulation 
(18). Krumbhaar (19) states that the spleen is directly concerned 
with fetal erythropoiesis and that, upon physiological demand during 
later periods of life, it may revert to an erythropoietic status. 
Many functions have been ascribed to the spleen. It removes 
11 wornout11 erythrocytes from the circuJa tion and manufactures bilirubin 
from the hemoglobin in these cells. It liberates this bilirubin for 
processing by the liver. Iron is also extracted from the hemoglobin 
in these cells for future use by the bone marrow. Many of the circu-
lating lymphocytes and probably most of the circulating monocytes are 
produced in the spleen (17). 
The sequestration of erythrocytes appears to be dependent upon 
the degree of erythrocyte injury rather than the type of injury. 
Slightly injured erythrocytes are removed from the circulation almost 
exclusively by the spleen. Moderate injury causes removel by both the 
spleen and the liver. Cells severely damaged are removed at a very 
high rate by the liver. It is suggested that the spleen has the capa-
bility of detecting smaller changes in the erythrocytes undergoing 
various types of damage ( 20). 
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Bennett and co-workers have reported the active removal of micro-
organisms from the circulation by the ~pleen ( 21); weight for weight, 
it is more effective than the liver (22). 
Hypersplenism has been used to descrihe "hyperrrormallf splenic 
function, Le., a larger-than-normal spleen associated with anemia, 
leukopenia, granulopenia, and thrombopenia usually accompanied by 
concomitant bone marrow hyperplasia. Following splenectomy, the blood 
picture usually becomes normal (2J). 
Many writers list the spleen as a specific reservoir of blood 
(24, 25, 26, 27). Schalm (27) states that the spleen is a significant 
reservoir of erythrocytes in the dog and the horse.. Zetterstrom (28) 
has shown that this function in the dog is greatly impaired by dener-
vation. 
Turner has reported highly variable jugular hematucrits in sheep 
due to splenic pooling (up to 1/4 the erythrocyte mass) as related to 
neurogenic factors; Le;, handling, excitement, etc. ( 29). The writer 
has not observed this variability in the calf. 
Following splenectomy, appearance of increases of the following 
elements have been reported in various animals: leptocytes (target 
cells), reticulocytes, Howell-Jolly bodies, nucleated erythrocytes, 
siderocytes, and Heinz bodies . (30, Jl) . According to Craddock (32), 
there is evidence that the erythrocyte becomes less fragile, i.e., 
more resistant to destructive agents and hypotonic salt solutions. 
In the dog a marked, but sometimes inconsistant, postsplenectomy 
anemia occurs due to inhibition, or lack of stimulation, of erythro-
poiesis (JJ). The writer has not observed this postsplenectomy in the 
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calf. Crosby has suggested that postsplenectomy anemia is' due to lost 
splenic reservoir function and subsequent reduction of the erythrocyte 
ma-s s (.31 ) . 
Mezhlumyan's work in the .rabbit indicates that significant .regen-
eration of the spleen is possible after extensive subtotal splenectomy. 
Regeneration can be stimulated by the use of "antireticular cytotoxic 
serum" and ethanol.amine (J4). There is evidence for some sort of 
humoral control to splenic size_ Rega.rdles.s of the number of splenic 
implants after subtotal or total. splenectomy, the final regenerated 
mass very closely approximates the original splenic weight (Jl.). 
Experimental atrophy·of the· spleen-has been induced in animals 
by removal of the pituitary-gland. Conversely, splenectomy has been 
shown to cause pituitITT'.'y -enl:arg:emmt ( J5). 
The spleens of the dog. and·guinea pig have beenshown to be cap-
able of removing endotoxin, in vivo. (J6, J7). However, presumably 
because of its location in the circulation, it was not found to be 
significantly important in this role. Splenectomized guinea pigs were 
no more susceptible to endotoxin than intact animals (J7). 
The spleen is thought t·o be- a complicating factor in the study of 
Factor VIII Hemophilia (A.H .. F .. -Anti-Hemophilic Factor). While it does 
not produce k.H.F-o, ft has be-ens shown to store significant. quantities 
of A.H.F. ( J8). Henn ( J9) reports a greatly shortened coagulation 
time in the splenectomized dog, but little chang.eunde-r similar condi-
tions in the rat and rabbit. 
It is well known that the spleen produces antibodies in response 
to an antigenic stimulus ('17, J9, 40, 41). .Although..detectable anti-
body production may or may not indicate immune protection (42), sev-
eral writers report positive correlations between increases in the 
incidence of fulminating infections and splenectomy of the less than 
one year old child (43, 44). Rogers, et al. (~.5) have shown a posi-
tive relationship between the concentration of circulating globulin 
components and Anaplasma complement-fixing (CF) titer. 
Schenberg (46) has demonstrated that as a primary response to an 
antigenic stimulus there is a rapid appearance of 19S macroglobulin 
antibodies. He presents strong evidence for the production of 19S 
globulin by large basophilic cells in the spleen (which resemble, and 
may be, large lymphocytes) and production of 7S globulin by plasma 
cells. This is consistent with Andersen's (47) report that splenec-
tomy significantly decreases circulating gamma-M-macroglobulins (19S) 
in the guinea pig. A significant decrease in circulating immuno-
globulins has been shown in the rat after 80 percent subtotal splen-
ectomy (49), Borel (41) quotes Davidson as saying that the rabbit 
spleen is responsible for the formation of 7S antibody in the anam-
nestic response. He also states that the 19S antibody "immunologic 
memory" is short in contrast to that of the 7S antibody. 
The study of the pre and postsplenectomy responses is somewhat 
complicated by the observation of various writers that the antibody 
response is dependent upon antigen, dose and route of administration, 
(40, 46, 47, 48, 49). Saslaw (40) has shown that there is no diff-
erence in antibody response of the intact splenectomized monkey when 
the antigen was given via the subcutaneous route, HoweverJ when the 
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antigenic stimulus was given intravenously, there was·significantly 
less antibody response in t __ he splenectomized animals .than in the con-
trol intact group. 
Borel (41) states that in the neonatal rabbit Ia.rge antigen doses, 
given intraperitoneally, produce a persistant anamnestic response in 
the 19S antibody. The same response is seen with a small intradermal 
dose. Small intravenous antigen doses produce only a 7S anamnestic 
response capability. 
In intraperi tone al injections of mice with sheep erythrocytes, 
the sequence of antibody production was found to.be spleen, pancreatic 
lymph nodes and mesenteric lymph:nodes (50). In the mouse and rabbit 
the lymplrnodes developed imni.tmologic competanc.e 48 hours later than 
splenic cells (50).. Murphy:·(4) has shown that the bovine animal res·-
ponds with l 9S .. 7S anti body prmfoction during· anapfasmosis .• ( See 
Appendix - Calf 84E and Calf 1049, Figures 45, 46, 47, 48). 
The observations cited above seem to verifythewords of 
Krumbhaar ( 19) : 
''The mammalian spleen, while not.necessary for the maintenance of nor-
mal existence and sharing .. many of its functions with other members of 
the hemolyto .. poietic systerri:, is :.useful :Ln several ways and an organ 
whose presence under certain stresses.may even be the deciding· factor 
between life a.nd death. Its func.tions are largely indicated by its 
structure, its ret'iculoendothelial cell content and by the changes 
produced in other organs by its absence." 
CHAPTER II 
EXPERIMENT.AL DESIGN AND METHODS 
This study was undertaken in an attempt to better de-scribe the 
relationship of the spleen to the anemia of anapl.asmos.is in the calf, 
There are five treatment groups. 
Classification of Treatment Groups 
Treatment Group I. The.primary disease in the intact calf: six 
normal uninfected* calves were inf-ected with anaplasmosis and the sub-
sequent disease course recorded, 
Treatment Group II,· The primary postsplenectomy anemia relapse 
in the calf: six anaplasmosis carrier calves were splenectomized and 
the subsequent disease course recorded., These are different animals 
from those used in Group I, 
Treatment Group III,, The primary disease response in the splenec-
tomized calf: six normal uninfected calves were surgically splenec-
tomized. Six weeks after spleneetomythe calves were infected and the 
subsequent disease course recorded. 
Treatment Group IV. The effect of laparotomy on the anaplasmosis 
*Uninfected, unless otherwise defined, means free of anaplasmosis 
as determined by two or rri.ore negative compliment fixation tests for 
anaplasmosis (51). 
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carrier calf: laparotomies and splenic manipulations (without removal) 
were performed· an five carrier calves. The postlaparotomy means were 
established from data taken during the period of expected maximum 
anemia. This period was days 11+811' through "+1211 • Day 11011 was desig-
nated as the twelfth day after laparotomy since the Group II calves 
showed 1 percent parasitized erythrocytes twelve days(on the average) 
after splenectomy.. The period of maximurrr::anemta· in the Group II calves 
a-ls o oocurred on days +8 through + 12 • 
Treatment Group V, A comparison of pre and postsplenectomy hema-
tological. values in the same calf: presplenectomy "norma-1" values 
were established. on six normal uninfected calves using five observe-
tions per calf to calculate the means.. Six weeks a-f-ter splenectomy 
new means were calculated using the previously·described regimen. 
Experimental Procedure 
The data presented in this study were obtained using recognized 
procedures ,(52). Where .it was found necessary to ·modify existing pro-
cedures, the 'modification of the procedure is described. 
Five or more pretreatment deterrn:trrations were made on each test 
,. 
for each animal to establish normal values. In general, each test 
was_ performed 2 or 3 times weekly. during the pre.patent period, daily. 
during the acute arremtc phase of the patent period and 2 !!Jn'.1 3 times 
weekly during the convalescent period of the pat~ent period. The on-
set of patent disease was defined as the first day that 1 percent of 
* the erythrocytes contained anaplasma bodies. 
*These were counted on Wright's stained bTood films with a light 
microscope. 
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Experimental Animals 
Calves of mixed breed and sex weighing less than 250 lbs. were 
obtained from institutional and local herds. They were maintained 
on a standard commercial calf feed, supplemented with steamed bone 
l * d ' 1 't .. t . 1 · t" ** mea. ·· an a commercia vi amin- race minera prepara ion , Prairie 
and alfalfa hay were fed free choice. The animals were given free 
access to water from the municipal water supply., They were maintained 
under standard conditions of husbandry throughout the study period. 
During the three to six week pre,-experiment acclimatization period, 
the animals were vaccinated against Clostridium_chauvoeLand septica, 
Leptospira pomona and treated with phenothiazine for internal para-
sites. Periodic fecal flotation examination, using saturated sodium 
sulphate, indicated that internal parasites were not a problem dur-
ing the experimental period.. Animals were top sprayed twice a month 
with a topical chlorinated hydro-carbon insecticide for external 
parasite control. 
Exposure to Anaplasmosis 
Prior to experimental infection, a negative reaction to the com-
plement fixation test for anaplasmosis was used as the basis for 
selecting a calf free from the disease. Each animal was inoculated 
subcutaneously with 5 ml. of carrier blood from a known infected cow. 
*Superior Feed Mills, Oklahoma City, Oklahoma, 
**Clovite, Fort Dodge Laboratories, Fort Dodge, Iowa. 
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The carrier blood was treated with neoarsphenamine (25 :mg. per 10 ml. 
of whole blood) at 40·degrees Fahrenheit for 24 hours to eliminate 
possible eperythrozoon organisms·in the carrier blood (53). All 
animals in each treatment group received treated blood from the same 
container at the same time with the exception of Treatment Group I, in 
which each half of the group was infected from separately prepared 
containers.* All cattle subsequently became infected. This technique 
provides, as nearly as possible, the same infective dose for each 
animal. 
Hematology 
Blood samples were drawn between 6: 30 and· 8: JO a~m. from the 
jugular vein into tubes containing 10 mg... of dry· dipotassium ethyl-
enediaminetetraacete (EDTA) for hematological studies the same day.** 
At the sa:ine ti:ine IO ml. of whole blood was co,Ilected and set, a,side at 
room temperature (approximately72 degrees Fahrenheit) for serum 
separation.. The coagulated blood sam,ple was centrifuged each after-
noon, the serum decanted, frozen at ~10 degrees Fahrenheit, and stored 
for later examination. 
Erythrocyte counts were done by standard laboratory proced11:res 
using an electronic grid partical counter+ with a lDOu aperture tube. 
*This was done because of its relation to another experiment to 
be reported separately. 
**Animals were either bled in their stable or moved to an adjacent 
chute handling facility for bleeding. 
+coul ter Counter, Maclel B, Coulter Electronics Co,,., Hialeah, 
Florida. 
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The counter control settings· were amplitude ~4; · current - 0.177; lower 
threshold - 7 (erythrocytes); upper threshold - ·· open ( full counter-
clockwise); threshold control switch - "separate" position. To reduce 
the coincidence factor, the standard erythrocyte dilutions were doub-
led. 
The raw count was corrected for coincidence using the company 
recommended chart; the background count of the saline diluent was 
subtracted out, and the resultant number doubled to · g-ive the final 
true count. The reproducibility, accuracy, and simplicity of the 
electronic counting technique is well documented and will not be 
dealt with here (54). Theoretically, this, technique can increase the 
statistical accuracy of individual cell counts by a factor of 10 over 
standard hemocytometer hand counting.methods; this is in accordance 
with.our.laboratory findings and those of,others (55). Repetitive 
., 
counts on the·same sample ustng the hemocytometer w.ere .far:more 
variable tl}an similar counts usfn·g the electronic grid technique. 
Packed cell voluip.es (P.C. V,,) were determined usipg the micro-
capillary tube method and a microhematocri t centrifuge {56}. Each 
. * sample was measured on an International rotary reading unit. 
Hemoglobin determinations were made colorimetrically using the 
acid hematin technique (57). ·A·60 minute color developing time and 
a reading wavelength of 525 IIlII1u we.re used. 
Blood films of the erythrocytes were made with the coverslip 
technique and counterstained with Wright"s stain. A quantity of 
*International Elect:ric Co.", Evanston, Illinois. 
distilled water buffered to pH 6.8 with phosphate buffer, equal to 
the amount of stain, was used to dilute the Wright's _stain. The 
stained smears were washed in approximately neutral distilled water 
(58). 
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The percentage of erythrocytes (PPE) containing anaplasma bodies 
among 500 red blood cells was estimated from the stained blood smears. 
A Whipple's disk was placed in the microscope ocular to facilitate 
_counting. The total number of infected erythrocytes (PRBC) was deter-
mined by multiplying the total erythrocyte count by the percent of 
infected erythrocytes. 
The estimates of average erythrocyte size (Mean Corpuscular 
Volume-MCV) and cell hemoglobin contents (Mean Corpuscular Hemoglobin 
Concentration-MCHC) were made using the standard erythrocyte indices 
calculating formulae (59). 
The compliment fixation (CF) test for anaplasmosis was used to 
detect antibodies produced against anaplasma and their by-products 
(51). A modification of the photoelectric nephelometric method was 
used to interpret the CF reaction. (See Appendix Figure 44). A posi-
tive reaction was reported as the log to the base 10 of the denomina-
tor of the highest dilution giving a 4+ reaction. This method was 
chosen to facilitate electronic data processing of the CF titers. 
CHAPTER III 
TABULATION OF DATA 
The tabular and graphic system used in reporting the results is 
a slight modification of that used by Brock (l)~ It has been shown 
that data from various animals can best be combined by adjusting them 
to some common phase point in the disease (60). In this case, the 
data of each animal was adjusted to the day in which 1 percent of the 
erythrocytes was first observed to contain.anaplasma bodies. Daily 
means within treatment groups were cal.culated on this bas ms. This day 
was .. designated as Day Zero ( 110"), the start of the patent period~ The 
prepatent days were designated with a minua· sign, and the days of the 
. .. . 
patent period w.ere de~ignated. with a plus sign. 
Values for the fo:jTowing tests were · reported · in tabular form as 
.actual values and in graphic fo·rm as perceutage deviations from pre-
treatment mean (X) valuef3. The following abreviations were used: 
HB - Hemoglobin, !}ms. per 100 ml. whole blood. 
POV - Packed Cell Volume, Volumes percent. 
·RBC - Erythrocyte count, x 106 cells per rnm. 2 
MGV - Mean Corpuscular Volume, cubic microns. 
MOHO - Mean Corpuscular Hemoglobin Concentration, percent. 
'PPE - Percent Parasitized Erythrocytes, percent~ 
PRBC - Parasitized erythrocytes, x 106 cells per rnm.2 
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CF - Complement Fixation Titer, log10 of the reciprocal of the 
highest titer giving a 4 + reaction. (See Appendix Figure 44). 
X - Pretreatment "normal" mean value. 
N - Number of animals in the group. 
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TABLE I 
PRIMARY DISEASE RESPONSE IN THE INTACT CALF. THE DAILY MEAN 
VALUES OF TESTS PERFORMED ON GROUP I: N = 6. 
Days HB POV RBC MCV MCHC PPE PRBC CF 
-
x 8.9 31.1 8.39 37.5 28.4 0.0 0.000 0.00 
- 48 8.9 34.5 7.75 44,5 25.7 0.0 0.000 0.00 
- 43 8.0 30,4 8.24 37 .o 26.2 0.0 0.000 0.00 
- 38 8.7 31.2 8,33 37 ,4 28.1 0.0 0.000 0.00 
- 35 8.~6 29.2 8.12 35,9 29.6 o.o 0.000 0.00 
- 30 8,8 29.5 8.15 36.3 29.8 0.0 0.000 0.00 
- 28 9.1 31.3 8.49 36,9 29,2 o.o 0.000 0.00 
- 24 8.7 2.88 8.07 35.7 30.2 0,0 0.000 0.00 
- 21 8.8 30,7 8.16 37.7 28.8 0.0 0.000 0.00 
- 18 9.6 32,6 8.93 36.5 29,3 0.0 0.000 0.00 
- 15 9 .• 6 32.3 9.65 33.5 29.8 0.0 0.000 0.00 
- 13 9.8 32.6 9.89 33.0 29.9 0.0 0.000 0.00 
- 10 9.5 26.1 10.13 25.7 36.5 0.0 0.000 0,00 
- 9 0.00 
- 8 9.4 33.2. 10.08 33.2 28.4 0,0 0.000 0.95 
- 7 2.91 
6 2.91 
- 5 9.6 30.1 10.19 29.8 31.9 0,0 0,000 2.96 
- 4 2.51 
- 3 2.81 
- 2 9.8 31.0 9.99 31.0 31.5 0.0 0.000 2. 58 
- 1 3,33 
0 9.6 29.9 9.19 32.6 31.9 LO 0.092 3.11 
+ 1 9.3 30,3 9.19 33,0 30.6 2.5 0,230 3,23 
+ 2 8.9 29.3 8.22 35.9 30.1 3.7 0.307 3.17 
+ 3 8,4 28.7 8.00 35.8 29.3 4,7 0.376 3.26 
+ 4 7.8 26.0 8,44 30.8 30.0 7.0 0.591 2.74 
+ 5 7.2 23.3 7.37 31.6 31.0 8.7 0,641 3.31 
+ 6 6.4 21.2 6.10 34,9 J0.2 10.0 0.610 3.16 
+ 7 6,2 19.7 5.93 33.2 31.2 1L8 0,700 3,36 
+ 8 5.6 17.8 4,99 35 .8 3L2 10.2 0.509 J,42 
+ 9 4,8 15 .8 4,38 36.0 30.8 9.1 0,400 3.23 
+ 10 5.1 16.8 4,31 39.0 30.2 9.2 0.400 3,31 
+ 11 5.1 16.8 4,28 39.3 30.l 8. 3 . 0.355 3.06 
+ 12 5 .. 5 18.3 J.73 49.3 30,l 6,8 0.254 3.11 
+ 13 5.7 19.3 3.90 49.6 29.7 4,6 0.179 3.18 
+ 14 6.4 20.9 4.20 49.8 30,6 2 7 0,113 3,16 
+ 15 6,4 2L3 4.56 44,8 30.1 Ll 0.050 3.11 
+ 16 6,4 22.0 4,55 48.5 28.9 2.2 0.100 3.11 
+ 17 6.9 23.0 4,34 53.0 29.8 1.8 0.078 3.26 
+ 18 7.1 24,3 4.09 59.5 29.l L4 0.057 3.11 
.Table I 
Da;ys __ 
+ 19 
+ 20 . 
+ 21 
+ 22 
+ 23 
+ 25 
+ 28 
+ 32 
+ 35 
+ 38 
+ 44 
+ 46 · 
(Continued) 
HB 
7.5 
7.5 
8.3 
8~6 
9.2 
10.1 
10.0 
10.1 
9.9 
PCV 
24.5 
25.5 
26.9 
28.9 
30,1 
31.3 
32,8 
34,0 
33,9 
I 
I 
', 
RBC 
4.61 
4.40 
5.25 
5.54 
5 .87 
6. 77. 
7.20 
7.82. 
8,63 
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'" 
MCV MCHC' .. PPE PRBC CF 
3.11 
53.J 30.1 1.2 0.055 3.11 
3.11 
;58.0 29.3. 1.6 0.070 3,11 
3,18 
51.J 30.8 0.5 0,026 2.99 
52.2 29.9 0.5 0.028 2.86 
51.3 30.6 0.0 0.000 2.69 
46,3 32.3 0.0 0.000 2.66 
45.6 J0.5 0.0 0.000 2.71 
43,5 29.6 0.0 0,000 2.57 
41,7 29.3 0,0 0.000 2.J5 
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TABLE II 
PRIMARY RELAPSE IN THE SPLENECTOMIZED CARRIER_ CALF. THE DAILY MEAN 
VALUES OF THE TESTS PERFORMED ON GROUP II: N = 6. 
··:oays · .. -HB PCV HBC MCV MCHC PPF PRBC CF 
x 9.7 29.4 7.61 38.6 32.9 0.03 0 ..•. 002 1.88 
- 31 9.4 28.2 6,94 40,6 33,,4 0.03 0.002 * 
- 27 - 9.6 29.0 7.43 39.0 31.8 0,03 0.002 * 
- 24 9.4 29.4 7,33 40.1 31.9 0.03 0.002 
* 
- 21 9.5 28.8 7.77 36,3 33.1 0.00 . 0.000 2.51 
- 18 9.2 27.8 7.77 . 35 .8 32.9 0,03 0.002 2.21 
- 13 10.7 30.7 7.69 39.9 34.7 0.03 0.002 1.80 
- 10 9.0 29.8 7.95 37.5 30.1 0.01 0.001 1.78 
- 7 10.4 31.5 7.96. 39.6 33.0 0.03 0.002 1.42 
;... J 10.6 29.7 7.71 38.5 J5.6 0.03 0.002 1.58 
0 10.,4 30.9 8.03 38.5 33,6 0.96 0.077 0.75 
+ 2 9.3 28.2 7.25 J8.9 32.9 4.00 0.290 
+ 3 8.9 26.7 7.20 37.1 33.3 6.90 0.497 0.70 
+ 4 8.7 25.6 6.87 37 .3 33,8 10.10 0.694 
+ 5 8.2 24.6 6.48 37 .9 33.1 13.50 0.875 1.02 
+ 6 7.3 22.2 5.28 42,0 32.8 20.60 1.088 
+ 7 6.0 19.2 4,85 39.6 3Ll 26.80 1.300 1.24 
+ 8 4.9 15.5 4,07 38.1 31 .6 25.60 1.042 0.87 
+ 9 4,0 12.2 2.87 42.5 33,0 21.70 0.623 0.75 
+ 10 3.2 11.5 2.70 42.3. 27.5 15.50 0.419 1.07 
+ 11 3.4 12.4 2.47 50.2 27.1 8.90 0.220 0.92 
+ 12 3.6 13.9 2,29 60.7 25.5 5.00 0.115 1.08 
+ 13 4.2 15.1 2.56 - 58.9 27 .5 2.60 0.067 i.28 
+ 14 4 .• 6 16.5 2.61 63.2 27.9 1.20 0.031 1.23 
+- 18 5.8 20,9 3.38 61.8 27 .8 0.22 0.007 . 1.72 
+ -21 6.5 22 .. 8 3.38 67 .5 28.J 0.31 0.010 1.48 
+ 25 5.9 20.4 3.16 64;6 28.7 0.43 0.014 1.46 
+ 28 6.2 20.3 3.96 51.3 30,4 0.27 0.011 2.20 
+ 31. 5.6 19.8 3,84 51.5 28.4 0.49 0.019 
+ 35 5.8 19.3 3.79 50.9 30.2 0.72 0.027 2.51 
+ 42 6.3 21.1 4,04 52.2 29.6 0.03 0.001. 2.20 
+ 47 7.2 23.0 5.00. 46.0 31.3 0,03 0.002 1.90 
+ 49 6.7 22.6 4.85 46.6 ·. 29.6 0.05 0.002 1.60 
*Titer not available: {t +@ 1/10. 
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TABLE III 
PRIMARY DISEASE RESPONSE IN THE SPLEN.ECTOivfIZED CALF. THE DAILY MEAN 
VALUES OF THE TESTS PERFORNrED ON GROUP III: N = 6. 
Days HB PCV RBC M.GV MCHC PPE PRBC CF 
-x 10.4 J0.5- 7.68 J8.7 J4.0 0.0 0.000 0.00 
- 46 9.6 29.9 7 .7J 
* 
.32.2 0.0 0.000 0.00 
- 44 10.0 JO~O 7.75 * JJ.2 0.0 0.000 0.00 
- 42 10.J JO .. O 7.75 
* 
·J4.J 0.0 0.000 o.oo 
- J9 10.4 J0.5 7.88 
* 
J4.l o.o 0.000 0.00 
- J7 10.7 J0.7 7.92 
* 
J4.8 o.o 0.000 0.00 
- J5 10.6 J0.4 7.86 * J4.9 o.o 0.000 0.00 
- J2 10.5 J0.9 7.99 * J4.l 0.0 0.000 0.00 
- JO 10.5 J0.5 7.88 * .34.J o.o 0.000 0.00 
- 28 10.1 29.8 8 . .36 J5.6 35.J 0.0 0.000 0.00 
- 25 10.7 Jl.O 6.08 51.0·. .34.6 0.0 0.000 0.00 
- 2J 10.5 J0.9 7.67 40.J J4.0 0.0 0.000 0,00 
- 21 10.0 29.6 7.15 41.5 JJ.7 0.0 0.000 0.00 
- 19 10.5 . 29.7 7.26 40.1 J5.J o.o 0.000 0.00 
- 18 10.2 29.5 7.98 J7.0 .34. 5 o.o 0.000 0.00 
- 17 10.J 29.8 8.JO J5~9 J4.5 o.o 0.000 0.00 
- 16 10.2 28.8 8.05 J5.7 J5.5 0.0 0,000 0.00 
- 15 10.7 29.4 76. 7 J8.J J6.2 0.0 0.000 0.00 
- 14 10.5 28.7 7.56 J7 .9 J6.7 o.o 0.000 0.00 
- lJ 9.8 29.J 7.Jl J4~6 JJ.J o.o 0.000 0.00 
- 12 10.5 28.6 7.42 J8.7 J6.7 o.o 0.000 0.00 
- 11 10.9 28.8 7.48 J8.6 J7.7 0.0 0.000 0.00 
- 10 10.1. 29.1 8.8J J2.6 . J4:.6 0.0 0.000 0.00 
- 9 9.9 29.J 8.9J 32.8 JJ.7 o.o 0.000 0.00 
- 8 9.8 28.2 8.8J Jl.9 .34.7 0.0 0.000 o.oo 
- 7 9.J 28.8 9.14 Jl .• 5 J2.2 0.0 0.000 0.00 
- 6 9.6 29.6 9~06 J2.6 J2.5 o.o 0.000 0.00 
- 5 9.4 29.8 9.47 JL,4 Jl ..• 6 o.o 0.000 0.00 
- 4 9.6 29.6 8.95 JJ .. l J2 .. J o.o 0,000 0.00 
- J 9.9 JO.O 9.52 Jl.5 JJ,l o.o 0.000 0.00 
- 2 9.9 JO.O 9.52 31.5 JJ.l 0.0 0.000 0.00 
- 1 9.6 29.3 9.46 30.9 32.7 0,3 0.003 0.88 
0 9.1 27 .9 10.09 27.7 32.6. 1.1 0.114 1.16 
+ 1 9.4 28.6 8.95 32.0 32.7 J.3 0.292 2.10 
+ 2 9.2 28.0 9.28 30.2 J2.8 3.6 0.335 2.25 
+ 3 9.2 · 28.1 8.12 34.6 J2.6 6.6 0.532 2.40 
+ 4 9.J 27 .8 8.05 34.6 33.2 9.9 0.794 2.45 
+ 5 8.3 26.2 7.48 J4.9 31.5 . 14.8 1.108 2.50 
+ 6 7.5 22.0 6.35 J4.6 JJ.9 21.1 1.337 2.75 
+ 7 5.6 16.8 5.30 31.6 JJ.l 27.2 1.442 2.90 
+ 8 3.8 11.8 3.80 30.9 32.2 35.4 1 . .343 J.05 
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!able III (Continued) 
Days HB. JidiT' ·- .. RBG MCV MCHC PPE PRBC CF 
+ 9 2.9 9.5 2.80 J4.l JO.l J5~J 0.985 J.04 
+ 10 .. 2.5 8.J 2.JO J6.2 JO..O 19.7 0 ,452. J.02 
+ 11 J,4 10~8 1.82 59.1 Jl.6 14.,9 0.271 2.87 
+ 12 J.7 lJ.l 2 •. 10 62.8 27.8 10.1 0 .2.12 J.25 
. +· lJ 4,J 14.,J 2.2J 4J.l JO.l 6.6 0.148 J.25 
+ 14 4 • .4 16.1 2.J6 68~.o 27.5 J.9 0.092 J.25 
+ 16 5.2 18.4 ·2,96 62.0 28.J 2.2 0.065 2.80 
+ 17 5.9 19.J J.10 62,.J J0.6 .1.5 0.046 J.02 
+ 18 6.6 20,.4 · ' J~Jl 61.5 J2 .• J .. l.J 0.042 J.17 
+ 19: 6.9 21.6 J.74 58.0 Jl..9 0.7 0.026 J.25 
+ 20 7.1 22 .. 2 J.-28 67 .1 J2.0 0.5 0.015 J.17 
+ 21 7.1 22.7 J,.66. 62.2 Jl.4 0.8 O.OJO J.02 
+ 2J 7.7 23.9 J.74 64.0 J2.l 1. ... 0 O,OJ7 2.95 
+ 24 7.6 24.;,l .. 4~09 ·59.,.1 JL .. J . ·. 4 .• 8 .. ·. Q'..l97 2.95 
+ 25 .• 7. 7 2J,.,9 .· 5.J6 44.5 J.2 ..• 1 5.5 0.292. J.02 
+· 26 7.6 2J.,.5 . 4. 95 47,.5 32~1 4,5 0.220 . 2.72 
+ 27 7 .J. 2J~6 J.69· ·64 .• 1· 
.. 
J0,7 . 3.0 0 .• 111 2.65 
+ 28 6.7 22.J 4.17 5J.4 JO.O J.O 0.125 2.65 
+ JO 6.4 21.9 4.27 49.8 J0.2 5.2 0.220 2.42 
+ Jl 6.8 2i.J . 4.J8 48 .. 8 Jl.7 5.2 0.229 2.57 
+ J2 6.8 . 21.4 4,17 51..2 Jl.7 4.5 0.118 2.50 
+ JJ 7.1 21.4 4,54 
.. 49.0 JL9 4.6 0.252 2.42 
+ J4 7.6 22.J J.45 64.8 J4.0 5.4 0.185 2.50 
+ J5 . 7 .1 22.4 5.55 40.7 Jl.5 7.1 O.J91 2.42 
+ J6 7.0 22.6 6.J7 J4.1 J2.J 9.6 0.608 2.50 
+ 37 6.9 2L7 4.J8 47 .6 JJ.l 8.1 O.J5J 2.42 
+ J8 6.4 20.9 . J.92 50.1 J2.5 7.0 0,274 2.12 
+ J9 5.7 19.6 J. 76 49.0 Jl.1 7.4 0.279 2.27 
+ 40 5.J 18,,4 J.JJ 51.4 J0.9 9.8 O.J25 2.42 
+ 41 5.4 17 .• 1 J,98 41.1 J2.8 8.8 O.J51 2.J5 
+ 4.2 5.1 16~4 J.70 4J.2 Jl.7 10.6 O.J90 2.57 
+ 44 5.2 15 .J J.59 42.5 34 .• 1 5.1 0.182 2.50 
+ 45 4,9 14.9 J.40 4J.9 J2.8 7.8 0.264 2.27 
+ 46 5.0 14.6 J. 75 . J9.0 J4,J 6.2 0,2Jl 2.27 
+ 47 5.1 16.1 J.40 47,4 Jl,8 4,0 0.1J6 1.97 
+ 48 5.4 15 .• 0 J.19 47-,l J6.0 5.6 0.179 1.97 
+ 49 5.8 16,6 J.47 48.0 J5.0 5.J 0.184 1.90 
+' 50 6.2 17.4 J.61 48.1 J5.8 6.0 0.214 1.90 
+ 51 5.9 17.8 J.5J 50.J JJ.2 5.9 0.207 1.90 
+ 52 6.1 18.6 J.54 52.7 J2.5 5.9 0.209 1.82 
+ 53 6.5 19 .• 6 J.95. 49.7 JJ.2 5.0 0.198 
+ 54 6.6 19.4 4.06 47 .8 JJ.8 5.1 0.208 
+ 55 6.9 19.6 4.22 46 .• 5 J5.2 5.4 0.228 
+ 5T. 7;0 19.9 J.87 51..J. J5.2 4.6 0.179 
* Due . to counting rnaphine malfunction, no RBC values were available 
for these days. Since pretreatment data appeared homogeneous, RBC 
counts were estimated for these days using the formula (daily PCV 
times MCV pretreatment mean= RBC estimated count. These estimated 
data do not enter in any st-atist:i.cal calculations. 
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TABLE _IV 
CONTROL LAPAROTOMY AND SPLENIC NfANIPULATION - CARRIER CALF. THE 
. DAILY MEAN VALUES OF THE TEST PERFORMED ON GROUP IV: N ::: 5 . 
Days HB PCV RBC MCV MCHC PPE PRBC CF 
x 10.0 JO.J 7.79 J8.4 32.8 0.10 0.009 2.50 
- JO 9.J .28.0 6.60 42.5 JJ.O O.OJ 0.002 * 
- 27 9.5 JO.J 7.J8 41.0 Jl.4 0.20 0.016 * 
- 16 10.1 JJ.5 8.42 39.8 JO.l O.JO 0.029 * 
- 12 10.8 32.2 8.62 Jl.J JJ.5 0.10 . 0,010 2.51 
- 10 9.6 Jl.O 7.66 40.5 Jl.0. 0.01 0.008 2.J8 
- 6 10.2 29.2 7.62 J8.J J5.l 0.01 0.005 2.57 
- J 9.8 29.8 7.8J J8.2 J2.6 0.00 0.000 2.51 
0 10.4 28 .. 9 8.17 J5,4 J5 .. 9 0.01 0.010 J.JJ 
+ 2 8.1 28.9 7.98 J6.l 28.2 0.20 0.018 2.28 
+ 4 10.6 JL7 7.96 J9.8 JJ.4 0.06 0.005 2.08 
+ 7- 9.6 29.2 7 .89 - J7.0 JJ.9 . O.OJ 0.024 2.20 
+ 8 8.0 28.6 7.75 J6.9 28.1 0.02 0.014 1.98 
+ 9 8.4 29.J 7.81 J8.0 28.8 0.02 0.012 2.20 
+ 10 10,4 28.3 7.78 J6.3 J6.7 0.02 0.019 2.02 
+ 11 9.6 28.0 7 ,74 36.1 ·34,2 0,02 0.019 1.84 
+ 13 10.0 30~3 7_.71 J9.J 32.9 0.02 0.014 2.08 
+ 15 9.J 28.4 7.61 37,4 32.7 0.01 0 .. 005 1.96 
+ 18 9.8 29.l 7.82 J7.2 JJ.8 0.02 0.014 2.97 
+ 22 9.J 29.0 7,84 J7.0 32.0 0.00 0.000 2.14 
+ 25 1.0.0 29.5. 7.68 J8.4 JJ .• 8 0.00 0.000 1.96 
+ 32 9.4 28.5 7.52 37 .9 32.8 0.01 0.005 1.90 
+ 39 9.1 29.l 7,14 40.7 Jl.2 -0.01 0.004 1.96 
+ 44 10.6 29.9 7,87 J8.0 J5.J 0.01 0.005 1.66 
+ 46 8.7 27 .. 8 7.06 39,4 Jl.25 0.01 0.004 1.55 
*Titer not available: 4 +@ 1/10. 
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TABLE V 
PRE AND POST SPLENECTOMY TEST VALUES IN THE CALF WITH NEGATIVE 
REACTIONS TO THE ANAPLASMA CF TEST - GROUP V: . N = 6 . 
. .. 
HB PCV RBC MCV MCHC * HB PCV 
Calf #06, 1 wk. presplenectomy Calf #06, 6 wks. postsplenectomy 
10.2 33,0 9.73 33,9 30.9 * 10.7 ,30.0 12.70 23.6 35.7 
9.4 32.0 8,45 37.8 29,4 * 9.9 29.0 11.76 24~6 34.1 
8 . 3 27 • 5 7 . 07 . 38 . 9 30 . 2 * 9 . 9 29 . o. 9 . 88 29 . 3 34 .1 
9. 0 29. 5 7-. 99 J6. 9 . • JO . 5 * 10. 7 JO. 0 11. 06 27 .1 35 . 7 
11,4 33.0 8.03 41.0 34,5 * 9.9 29.0 11.66 24.9 34.1 
Calf #07, 1 wk. presplenectomy Calf #07, 6 wks. postsplenectomy 
10.2 33.0 9.73 33.9 J0.9 * 11.4 32.0 12.36 25.9 35.6 
10.2 30.0 9.04 33.1 34,0 * 11.4 31,0 11.98 25.9 36.8 
10.0 34.0 8.97 37.9 29.4 * 11.0 32.0 12.72 25.1 34,4 
11.0 33.5 &.72 38,4 32.8 * 11.0 32.0 12.90 24.8 34,4 
10.7 33.0 9.44 34.9 32.4 * 11.6 3Z.O 11.30 28.J 36.2 
Calf #08, 1 wk. presplenectomy 
9.9 33.5 8.40 39.9 29.6 * 
9.9 33.5 8.69 · 38.5 29~6 * 
9.0 28.5 8.04 35.4 31.6 * 
10.5 33.0 8.39 39.J Jl.8 * 
11.4 35.0 7.38 47,4 32.6 * 
Calf #08, 6 wks. postsplenectomy 
8.3 29.0 10.58 27.4 28,6 
9.9 29~0 &.98 32.2 34.1 
9.9 28.5 7.JO 39.0 34.6 
10.7 JO.O 11.26 26.6 35.7 
9.9 29.0 10.94 26.5 34,l 
Calf #09, 1 wk. presplenectomy Calf #09, 6 wks. postsplenectomy 
9.0 JO.O 11.26 26.6 30.0 * 9.9 Jl.O 10.94 28.3 32.0 
7.8 28.0 7.40 37.8 27.8 * 10.2 31.0 11.10 27.9 33.0 
8. 8 29. 5 7 . 02 42 0 0 29. 8 * 10. 7 31. 0 9. 80 31. 6 34. 5 
7.8 26.0 6.38 40.7 30.0 * 11.0 29.5 10.10 29.2 37.2 
9.4 27.5 ~6.32 43,5 34.1 * 11~0 30.5 11.94 25.5 36.0 
Calf #10, 1 wk. presplenectomy Calf #10, 6 wks. postsplenectomy 
10.5 32.0 12.82 24.9 32.8 * 9.6 28.5 10.32 27.6 33.7 
9.9 31.0 7.43 41.7 31.9 * 10.7 30.0 9.72 30.9 35.7 
10.5 33.5 . 8.0J 41.7 31.3 * 11.4 31.0 9.62 32.2 36.8 
11.0 33.0 8.38 39.4 33.3 * 11.0 JLO 11.78 26d3 35.4 
10_5 31.0 7.18 43,l 33,9 * 10.5 30.0 9.06 33.l 35.0 
Calf #11, 1 wk~ presplenectomy 
9.0 30.0 8.00 37.5 30.0 
9.6 30.0 7.63 39.3 32.0 
8.8 28.0 6.36 44.0 31.4 
9.4 30.0 8.16 36.8 Jl.3 
10.2 34,0 8.51 40,0 30.0 
Caif #11, 6 wks. postspl.enectomy 
* 10.7 3G.O 12.12 24.8 35.7 
* 10.5 Jl.O 8.84 J5.l 33.9 
* 11.0 32,0 lJ.10 24.4 34,4 
* 10.7 32.0 9.98 32,0 33.4 
* 11.0 32.0 10.36 30.9 34.J 
CHAPTER IV 
DATA TRANSFORMATION 
Brock (1, 61) has suggested a percentage type of data trans-
formation to facilitate the comparison of various groups with differ-
ent pretreatment means. This was done by the construction of graphs 
which show the deviations, on a percentage basis, of the daily obser-
vations from the pre-treatment mean,.. In effect, this reduced the 
means of each treatment group to a common mean of zero, with treat-
ment effects (plus experimental error) demonstrated as plus or minus 
percentage deviations from zero. 
The following graphs (Figures 1 through 24) were constructed on 
a "mean zero" basis. A pre-treatment mean was calculated on five or 
more pre-treatment observations.., The percentage deviation was calcu-
lated: observation divided by pre-treatment equals the deviation. 
The deviation was multiplied by one hundred to convert it to whole 
percentage points and recorded with its plus- or minus sign. 
The graphs showing the numbers of parasitized erythrocytes and 
the graphs showing the CF titers normally have zero means. (Figures. 
25 through 33). No transformation was necessary for these observa-
tions, and they are given as changes in test values and not as per-
centage deviations. 
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Figure 1. Deviations of the grams of hemoglobin per 100 ml. 
of blood from the pretreatment mean ( x = 8.88 Gm.%) 
during the prepatent· and patent periods of anaplasmosis 
in Group I - The primary disease in the intact calf: 
N = 6. (Y-axis is expressed as percent change.) 
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Figure 2 . Deviations of the grams of hemoglobin per 100 ml. 
of blood from the pretreatment mean ( x = 9.74 Gm.%) 
during the prepatent and patent periods of anaplasmosis 
in Group II - The primary relapse in the splenectomized 
carri er calf: N = 6. (Y-axis i s expressed as percent 
change.) 
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Figure J. Deviations of the grams of hemoglobin per 100 ml. 
of blood from the pretreatment mean ( x = 10.J6Gm. % ) 
during the prepatent and patent periods of anapla_smosis 
in Group III - The primary disease response in the 
splenectomized calf: N= 6. (Y;,..axis is expressed as 
percent change.) 
+ 20 
x 
- 20 
- 40 
- 60 
- 80 
28 
11 11 ; : I, Ir 1, .-~ : I +r+rr • H+++-lf+ 
, ! I I -f+t-++ 
-40 -JO -20 -10 0 +10 +20 +JO +40 
PREPATENT DAYS PATENT DAYS 
Figure 4. Deviations of the grams of hemoglobin per 100 ml, 
of blood from the pretreatment mean ( x =:. 9, 96 Gm, % ) 
during the prepatent and patent periods of anaplasmosis 
in Group IV - Control laparotomy of the carrier calf: 
N = 5, (Y-axis is expressed as percent change,) 
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Figure 5. Deviations of the packed cell volume of blood 
from the pretreatment mean ( x = JLl Vol. % ) during 
the prepatent and patent periods of-anaplasmosis in 
Group I.,... The primary disease response in the intact 
calf: N":.:: 6. (Y-axis is expres~rnd as percent change.) 
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Figure 6. Deviations of the packed cell volume of blood 
from the pretreatment mean ( x :c: 29.4 VoL % ) during 
the prepatent and patent periods of anaplasmosis in 
Group II - The primary relapse in the splenectomized 
carrier calf: N = 6. (Y-axis is exp~essed as percent 
change.) 
JO 
.. 
+ 20 
x 
- 20 
- 40 
- 60 
- 80 
31 
-40 -JO -20 -10 0 +10 +20 +JO +40 
PREPATENT DAYS PATENT DAYS 
Figure 7. Deviations of the packed cell volume of blood 
from the pre:treatment mean ( x = J0.5 Vol.%) during 
the prepatent and patent periods of anaplasmosis in 
Group III - The primary disease response in the splenec-
tomized calf: N = 6. (Y-axis is expressed as percent 
change.) 
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Figure 8, Deviations of the packed cellvolume of blood 
from the pretreatment mean ( x = 30. 4 VoL % ) during 
the prepatent and patent periods of anaplasrµosis in 
Group IV - Control laparotomy of the carrier calf: 
N = 5. (Y-axis is expressed as percent change.) 
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Figure 9. Deviations of the number·of erythrocytes per 
cubic millimeter of blood from the pretreatment mean ( x = 8.39x 106/rrun. 2 ) during the prepatent and patent 
periods of anaplasmosis in Group I - The primary disease 
response in the intact calf: N = 6. (Y-axis is ex-
pressed as percent change,) 
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Figure 10, Deviations of the number of erythrocytes per 
cubic millimeter of blood from the pretreatment mean ( x = 7,61 x 106/mm.2) du.ring the prepatent and patent 
periods of anaplasmosis in Group II - The primary 
relapse in the splenect9mized carrier cal.f: N = 6, 
(Y-axis is expressed as percent change,) 
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Figure lL Deviations of the number .of erythrocytes per 
cubic millimeter of blood from the pretreatment mean ( x = 7068 x 106/mm"2) during the prepatent and patent 
periods of anaplasmosis in Group III - The primary 
. disease response in the splenectomized calf.: N = 60 
(Y-axis is expressed as percent change,) 
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Figure 12. Deviations of the number of erythrycytes per 
cubic millimeter of blood from the pretreatment mean ( x = 7.79 x 106/mm.2) during the prepatent and patent 
periods of anaplasmosis in Group TV - Control Iaparo-
tomy of the carrier calf: N = 5-. (Y-axis is e~pressed 
as percent change.) 
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Figure 13, Deviations of the mean corpuscular volume of 
blood from the pretreatment mean ( x =. 37 • 5 c . u. ) 
during the prepatent- and patent periods of anaplasmosis 
in Group I - The primary disease. response in the intact 
calf: N = 6. (Y-axis is. expressed as percent change.) 
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Figure 14. Deviations of the mean corpuscular volume of 
blood from the pretreatment mean ( x = 38.6 c.u. ) 
during the pre.patent and patent periods of anaplasmosis 
in Group II - The prim13..ry relapse in tb.e spl.enectomized 
carrier calf: N = 6. (Y-axis is expressed as percent 
change.) 
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Figure 15, Deviations .of the mean corpuscular volume of 
blood from the pretreatment mean ( x = J8.7 c.u. ) during 
the prepatent and patent periods of anaplasmosis in 
Group III - The primary disease response in the splenec-
tomized calf: N = 6, (Y-axis is expressed as percent 
change,) 
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Figure 16. Deviations of the mean corpuscular volume of 
blood from the pretreatment mean ( x = 38.4 c.u. ) 
duringthe prepatent and patent periods of anaplasmosis 
·in Group IV - Control laparotomy in the carrier calf: 
N = 5, (Y-axis is expressed as percent change .. ) 
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Figure 17 o Deviations of the mean corpuscular her:n.oglobin 
concentration of blood from the pretreatment mean ( x = 28,4 % ) during the prepatent and patent periods 
of anaplasmosis in Group I - The primary diseas'e res-
ponse in the intact calf: N = 60 (Y-axis is expressed 
as percent change,) 
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Figure 18" Deviations of the mean corpus.cular hemoglobin 
concentration of blood from the pretreatment mean ( x cc: J2o9 % ) during the prepatent and patent periods 
of anaplasmosis in Grrn.1.p II - The primary relapse in 
the carrier calf: N ,-c 60 (Y-axis is expressed as 
percent changeo) 
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Figure 19" Deviations of the mean corpuscular hemoglobin 
concentration of blood from the pretreatment mean ( x = 34,0 % ) during the prepatent and patent periods 
of anaplasmosis in Group III ".'"' The primary disease res-
ponse in the splenectomized calf: N = 6, (Y-axis is 
expressed as percent changeo) 
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Figure 20. Deviations of the mean corpuscular hemoglobin 
concentration of blood from the pretreatment mean 
C x = 32.8 % ) during the prepatent and patent periods 
of anaplasmosis in Group IV - Control laparotorriy in the 
carrier calf: N = 5. (Y-axis is expressed as percent 
change.) 
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Figure 2L Deviations of the percentage of parasitized 
erythrocytes in the blood during the prepatent and 
in Group I - The primary patent periods of anaplasmosis 
disease response in the intact calf: 
is expressed as percent change.) 
N = 6. (Y-axis 
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Figure 22" Deviations of the percentage o,f parasi tized 
erythrocytes in the blood during the p:repatent and 
patent periods of anaplasmosis in Group II - The primary 
:relapse in the splenectomized carrier calf~ N = 6" 
(Y-axis is expressed as percent change") 
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Figure 2J. Deviations of the percentage of :parasitized 
erythrocytes in the blood during the prepatent and patent 
periods of anaplasmosis in Group III - The primary disease 
response in the splenectomized calf: N = 6. (Y-axis is 
expressed as percent,change.) 
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Figure 24. Deviations of the percentage of parasitized 
erythrocytes in the blood during the prepatent and 
patent periods of anaplasmosis in Group IV - Control 
laparotomy of the carrier calf: N = 5. ( Y-·axis is 
expressed as percent change.) 
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Figure 25. Deviations of the number of parasitized eryth-
rocytes per cubic millimeter of blood during the pre-
patent and patent periods of anaplasmosis in Group I -
The primary disease response in the intact calf: N = 6. 
(Y-axis is expressed as erythrocytes x 106 per mm. 2 of 
blood.) 
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Figure 26, Deviations of the number of parasitized 
erythrocytes per cubic millimeter of blood during 
the prepatent and patent periods of anaplasmosis in 
Group II - The primary relapse in the sp1enectomized 
carrier calf N c:: 6, (Y-axis is expressed as eryth-
rocytes x 10' per mm, 2 of blood,) 
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Figure 27. Deviations of the number of parasitized eryth-
rocytes per cubic millimeter of blood during the pre-
patent and patent periods of anaplasmosi.s in Group III -
The primary disease in the splenectomized6calf: N = 6. (Y-axis is expressed as erythrocytes x 10 per mm.2 of 
blood.) 
L50 
L25 
LOO 
0,75 
0.50 
0.25 
0.00 
' '' 
-H: I, I, T-
i, I H _I 
1 'H-, r·,: 1+ 
-40 -30 -20 -10 0 +10 +20 +JO +40 
PREPATENT DAYS PATENT DAYS 
Figure 28. Deviations of the number of parasitized eryth-
rocytes per cubic millimeter of blood during the pre-
patent and patent periods of anaplasmosis in Group IV -
Control laparotomy of the carrier6calf: N2= 5. (Y-axis 
is expressed as erythrocytes x 10 per mm. of blood.) 
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Figure 29. Deviations of the complement-fixation reaction 
curing the prepatent and patent periods of anaplasmosis 
in Group I - The primary disease response in. the intact 
calf: N = 6. (Y-axis is expressed as the logarithm to 
the base 10 of the denominator of the highest dilution 
giving a 4 + reaction.. See Figure 44. ) 
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Figure JO, Deviations of the complement-·fixation reaction 
during the prepatent and patent periods of anaplasmosis 
in Group II - The primary relapse in the splenectomized 
carrier calf: 6, The area under the dotted line indi-" 
cates that although no high dilutions were madeJ the 
animals were CF positive at the standard titration of 
4 + at 1/10, (Y-axis is expressed as the logarithm. to 
the base 10 of the denominator of the highest dilution 
giving a 4. + reaction, See Figure 44, ) 
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Figure 31. Comparison of the complement-fixation reactions 
during the prepatent and patent periods of anc1pl.wmosis 
between subgroups of GroupII - The primary relapse in 
the splenectomized carrier.calf: N.= 3 for each sub-
group.. F = the· subgroup that had the earliest reduction 
in CF titer. 1 = the subgroup that had the later reduc-
tion. (Y-axis is expressed as the logarithm to the base 
10 of the denominator of the highest dilution giving a 
4 + reaction. See Figure 44,) 
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Figure 32, Deviations of the complement-fixation reactions 
during the prepatent and patent periods of anaplasmosis 
in Group III - The prima.ry diseas e response in the splen-
ectomized calf: N = 6. (Y-axis is expressed as the 
logarithm to the base 10 of the denominator of the 
highest dilution giving a 4 + reaction, See Figure 44 , ) 
3.0 
2,5 
2.0 
1.5 
LO 
0.5 
0,0 
·-- ·--·------ ---- --;- -· -: - ·- -------·-·--·-··- ··---··-------· ' ~--- -- ·---······ ·-·- _.· ____ , ___ .. __ .... ··-· .... _, 
::~~: :-~~~--~:-~-~~:.:.:=.:=--==~= : _-;-~=-~ :-=-:-=-~~=--=--~-~-~===~ ~~--·~-::: --~=:=.~::--:·. ::·.~_:::.::.:·.:.: .. 
.... ·······- ··-·-··-····-------------:-· - ·--·-----·--- -·--··--·-- -· . '------· -----------······· 
• • .... , •• ,, • ._ •••• •·•·•·•-•-· ··---,' '• ' ' 'I •-··-· •·•···-~··•-··-·•· •, --···--·•·••-··•·••• •·••-• •-•-•• 
- . -_- _- ___ •.. -·-------···-- _____ -:-.-r --------·· .... -~· ... - - .::--:-..:::---:-:-: --::.-:.-::~-:~~-: 
: ... -~ :_: : ~-~: -~ ·. :::·~~~~~=-=·~. ~- -~--~- ::-:_ ':::::=::: ::=-::--:.=:: : ~~-=-·=:=r' .-:~~~~-:·: 
..... ·-··- ··-----------------. -·- ·---------· - ··-·-·-·····---- -·-·-·---·····-··· .. 
·-····--· ----·- - . ~·--· ·-...:. -· --· .. . .. 
. ···-- ··--·---·- -,--~~ --- ·----· 
....... ······-···-·· -.--·- ··------·· ... 
... ---· ·--·--- ·····-·-··---·-- . ·--··········-
---- ···-·-···- ··-
. ··-·--···-···-···-·· .. - . ·-
···· - ....... ·-·· . 
-40 -30 -20 -10 0 +10 
······ 
···--·-··-··· 
. I 
+20 +JO 
PREPATENT DAYS PATENT DAYS 
5'7 
+40 
Figure 33. Deviations of the complement-fixation reaction 
during the prepatent and patent periods of anaplasmosis 
in Group IV - Control laparotomy in the carrier calf: 
N - 5. The area under the dotted line indicates that 
although no high dilutions were made, the animals were 
CF positive at the standard titration of 4 + at 1/10, 
(Y-axis is expressed as the logari t:tun to the base 10 
of the denominator of the highest dilution giving a 
4 + reaction. See Figure 44,) 
CHAPTER V 
RESULTS 
Comparison of the Treatment Groups Using Fitted Curves 
The following graphs are fitted curves taken from the individual 
group bar graphs, Although usual care was taken in fitting the curves, 
one should refer to the individual bar graphs for close analysis, 
The writer has omitted the Group IV control values from certain 
fitted graph comparisons, These values are represented by the zero 
mean (horizontal continuous line) since their deviations approximate 
zero. This was done to avoid duplication of essentially identical 
lines, These control values may be inspected in their respective bar 
graphs, 
Hemoglobin (Figure 34) 
The deviations noted in the late prepatent period (days -15 
through "0") appear to the writer to be definite changes, The pro-
gressive rate of fall in hemoglobin values appears to be the same for 
all three groups, The two groups of splenectomized animals give simi,-
lar responses and maintain low values throughout the observed patent 
period, The group of intact animals does not reach such low values, 
The values of the intact animals return to the prepatent "normal" 
values on day +JO and appear to "over-compensate 11 during days +JO 
through +50, 
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Figure J4. Comparison of the deviations of the hemoglobin 
values of blood during the prepatent and patent periods 
of anaplasmosis in: Group I - The primary disease res-
ponse in the intact calf; Group II - The primary re-
lapse in the splenectomized calf; Group III - The 
primary disease response in the splenectomized calf; 
Group IV - The control laparotomy i.n the carrier calf 
(this group omitted since it approximated zero), These 
fitted curves are taken from data in Figures 1, 2, J, 
and 4. (Y-axis is expressed as percent change.) 
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Packed Cell Volume (Figure J5) 
The fluctuati.ons of these curves follow those observed in the 
graph on hemoglobin, with the exception of the late prepatent changes 
(days -15 through 11 011 ), Only Group III appears to show significant 
changes in the late prepatent period. Again, the response of the two 
groups of splenectomized animals is similar and is more severe and 
of longer duration than the group of intact animals, The apparent 
over-compensation is noted in the intact animals beginning at day +JO, 
Numbers of Erythrocytes (Figure J6) 
The late prepatent response is quite marked in this graph, with 
all groups showing some degree of late prepatent elevation, During 
the patent period the two groups of splenectomized animals maintain 
low values and appear similar until the last pa.rt ( days +40 to +50) 
of the observed patent period, The similarity of shape of the curves 
of Groups I and II during the patent period should be noted, even 
though the difference of values is apparent, the long convalescence 
of the asplenic animals is dramatically different from that of the 
intact animals. 
Mean Corpuscular Volumes (Figure J7) 
The reduction of MCV is apparent in the late prepatent and early 
patent periods (days -10 through +10), On day +10, the start of a 
marked elevation in MCV values can be seeno Again, the asplenic 
groups appear similar (until day +28), The response of the intact 
animals was neither as marked nor as abrupt,· 
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Figure 35. Comparison of the d!;:!viations of the packed .cell 
volume values of blood during the prepatent and patent 
periods of anaplasmosis in: Group I - The primary disease 
response in the intact calf; Group II - The primary 
relapse in the carrier calf; Group III - The primary 
disease response in the splenectomized calf; Group IV 
Contr·ol laparotorny in the carrier calf.. These fitted 
curves are taken. from data in Figures 5, 6, 7, and 8. 
(Y-axis is expressed as percent change,) 
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Figure J6" Comparison of the deviations of the erythrocyte 
counts of blood during the prepatent and patent periods 
of anaplasmosis in: Group I - The primary disease res-
ponse in the intact calf; Group II - The primary relapse 
in the splenectomized carrier calf; Group III - The 
primary disease response in the splenectomized calf" 
These fitted curves are taken from data in Figures 9) lOJ 
llJ and 12" (Y-axis is expressed as percent change") 
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Figure 37. Comparison of the deviations of the mean cor-
puscular volumes of blood during the prepatent and patent 
periods of anaplasmosis in: Group I~ The primary res-
ponse in the intact calf; Group II - The primary relapse 
in the splenectomized. carrier.calf; Group IV - Control 
laparotomy of the carrier calf (this group is omitted 
because it approximated zero). These fitted curves are 
taken from data in Figures 17, 18, 19, and 20. (Y-axis 
is expressed as percent change.) 
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Mean Corpuscular Hemoglobin Concentration (Figure 38) 
The late pre patent period ( days -10 through rrorr) shows a differ-
ence in the response by Groups I and III. During the patent period 
there is an apparent long-term reduction in the MCHC values of the 
asplenic animals. There are two slight decreases in MCHC values (days 
+19 and +41) which appear to occur simultaneously in Groups II and III, 
The elevation of the MCHC in the intact group animals is related to 
the fact that this group had a lower MCHC pretreatment mean. (See 
Table I). 
Percentage of Parasitized Erythrocytes (Figure 39) 
The initial rate of rise is strikingly similar for all three 
groups. The asplenic animals maintain their high rate of change to 
their peak values. On day +2 the rate of change for the intact 
animals becomes reduced. The intact animals reach a considerably 
lower peak value. Group III maintains a marked parasitemia during 
the entire observed patent period.. The fitting of the curve to data 
for Group III for days +29 through +49 is problematical. It is 
suggested that the reader review Figure 23 before making judgement 
on this section of the graph. 
Numbers of Parasitized Erythrocytes (Figure 40) 
This graph is similar in form to that for the percentage of 
parasitized erythrocytes. (Figure 39). The rise and fall of the 
curves in Figure 40 precede those in Figure 39 by one to two days. 
It appears that the rise by Group III presents itself one day earlier 
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Figure J8, Comparison of the deviations of the mean corpus-, 
cular hemoglobin concentrations of blood during the pre-
patent and patent periods of anaplasmosis in: G.roup I -
The primary disease .response in the intact calf; Group 
II - The primary relapse in the splenectomized carrier 
calf; Group III - The primary disease response in the 
splenectomized calf; Group IV - Control laparotomy in 
the carrier calf (this group was omitted since it 
approximated zero), These fitted curves are taken from 
data in Figures 22J 23, 24J and 25. (Y-axis is expressed 
as percent change,) 
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Figure J9. Comparison of the percentage of parasitized 
erythrocytes of blood during the pr.epatent and patent 
periods of anaplasmosis in: Group I - The pr.imary 
disease response in the intact calf; Group II - The 
primary relapse in the splenectornized carrier calf; 
Group III - The primary disease response in the splenec-
tomized calf; Group IV - Control laparotomy in the 
carrier calf (this group was omitted sirice it approxi-
mated zero). These fitted c1.,1rves are taken from data 
in Figures 27, 28, 29, and JO. · (Y-axis is expressed 
as percent change.) 
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Figure 40. Comparison of the deviations of numbers of 
parasitized erythrocytes of blood during the prepatent 
and patent periods of anaplasmosis in: Group I - The 
primary disease response in the intact calf; Group II -
The primary relapse. in the splenectomized carrier calf; 
Group III - The primary disease response in the splenec-
tomized ca._lf; Group.IV - Control laparotomy of the 
carrier calf (this group was omitted since it approxi-
mated zero). These fitted curves are taken from data in 
Figures 326 33, 34, and 35. (Y-axis is expressed as 
cells x 10 per cubic millimeter 0£ biood,) 
than by the other groups. Attention is called to three points: 
(1) the rise and fall of Group III is different from the other 
groups, (2) the asplenic animals experience a higher parasitemia 
than do the intact animals, (3) a marked parasitemia persists only 
in Group III, 
Complement-fixation Reactions .(Figures 41 and 42) 
There is a very abrupt rise in the CF titer for Group L The 
rise is only less marked in Group IIL However, the appearance of 
the CF titer for Group III is seven days later than for Group I, 
Note the "notches 11 in Groups I and III which follow the peak titers 
by four days, There is another titer peak at day +44 in Group III, 
There is a marked postsplenectomy titer fall in Group II. (Review 
Figure 31 since "mean" data tends to mask individual responses.) 
Figure 42 shows.the splenic and asplenic response. (See explanation 
in the legend.) 
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Figure 41. Comparison' of the deviations of the complement-
fixation reaction: during the prepatertt. and patent periods 
of anaplasmosis in: Group I,.. The primary disease res-
ponse in the intact. calf; Group II·- The primary relapse 
in the splenectomized carrier calf; Group III - The 
primary disease response in the splenectornized. calf; 
Group IV - Control laparotomy in the·· carrier calf. These 
fitted curves are taken from data: in Figures 29; .30, .32., 
and 3.3. (Y-axis is expressed as the logarithm to the 
base 10 of the denominator of the highest.dilution giving 
a 4 + reaction. ) 
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Figure 42. Comparison of the complement-fixing titer rise 
response in the intact cal:f (A)" of Group I and the 
asplenic calf (B) of Group III" The data has been ad-
justed so the CF rises start together. (Y-axis is 
expressed as the logarithm to the base 10 of the denomi-
nator of the highest dilution giving a 4 + reaction") 
CHAPTER VI 
DATA ANALYSIS* 
A system of electronic data processing (EDP) using the I.B,M. 
** . 1620 was developed for analysis of hematological data generated in 
this set of experiments (62). Tukey's (63) "W" multirange test for 
unequal replicates was used to test for statistically significant 
differences between multiple treatment means. Student's "t" test was 
used on simple treatment pairs ( 64). 
The statistical tables are comparisons of certain-values during 
various phases of the disease of anaplasmosis. Values are reported 
as means, plus or minus their standard deviations. 
In the comparison of multiple means, the value of •rFrr is calcu-
lated by standard analysis of variance (AOV) procedure (65). Those 
values of "F" followed by(*) are considered to be statistically 
different at the P~05 level of significance; those values followed by 
( **) are considered significant. at the P.01 level •.. A "significant" 
value of "F" indicated that one or more of the means is different. 
Errors of "F" are considered to be decision-wise types of error. 
*The writer wishes to acknowledge the counsel of Leroy Folks, 
Ph.D~, Oklahoma State UniversityStatistical Laboratory, for certain 
statistical considerations in this analysis. 
**International Business Machines, Inc., New York. 
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Those means which are underscored by a continuous line,are not 
considered to be significantly different at the P.05 level, using 
Tukey's 11W" test. The er.rors of Tukey's "W" are experiment-wise types 
of error. 
When necessary to compare two treatment means, the Student's "t" 
method is used. Following a calculated value of "t", (*)or(**) 
indicate statistical significance at the P.05 and P.01 levels, 
respectively. The errors of 11 tfr are decision-wise errors. 
Mean values as encountered in the data tables and in the 
statistical analysis tables may vary slightly for the same group and 
the same test. They represent slightly different samples of the same 
original. raw data.. For example, pretreatment means in the data tables 
may be drawn from a slightly different period during the.prepatent 
phase9 .Also, another exampl.e would be the lowest value. reached by 
a certain test, i.e., the lowest value in the data tables is the 
lowest mean of s·ix animals reached on the same day~ In the statis-
tical tables-, the lowest value will represent the mean of the lowest 
value observed in each of the six animals., regardless of when that 
value occurred. 
1. 
2. 
3. 
1. 
2. 
Prepatent 
I 
8.8 ±. 0.9 
TABLE VI 
HEMOGLOBIN COMPARISONS+ 
"normal" values, HB - Gms, percent. 
II III IV 
9.6 ±. L4 10.3 .±. 0.4 9.9 ±. 0.4 
Lowest value at peak anemia, HB ... Gms, percent. 
I II III IV 
4.5 .±. 0.9 2.7 .±. 0.5 2.5 .±. 0,6 8.4 .±. 0.5 
Patent day lowest value RB reached, days. 
I II III IV 
9. 7 ±. 1..6 10.8 ±. LJ 9.3 ±. 0 .. 5 28 .o .±. 11. 6 
TABLE VII 
PACKED CELL VOLUME COMPARISONS+ 
Prepatent "normal" values, PCV - Volumes percent. 
I II III IV 
J0.4 ±. 2.0 29.8 ±. 2.2 J0,4 .i 1.1 30,8 .±. 2.1 
Lowest value at peak anemia, PCV - Volumes percent. 
II 
10.0 ±. 1.4 
III 
8 .• 5 ±. 0,5 
IV 
26.0 ±. L2 
J. Patent day lowest PCV reached, days. 
I 
9.6 :!:. 1.2 
+ I - Primary 
II Primary 
III Primary 
IV - Control 
II 
10.0 ±.. 1.6 
III 
9.8±,1.7 
disease response in the intact 
relapse in the splenectomized 
disease in the splenectomized 
laparotomy of carrier calf: n 
calf: n = 6. 
carrier calf: 
calf: n -· 6. 
- 5. 
73 
"F" 
2. 67 
"F" 
119,03** 
"F n 
14,57** 
n = 6. 
TABLE VIII 
'ERYTHROCYTE COUNT COMPARISONS+ 
1. Prepatent "normal!' values, RBC - x 106 cells per mm,2 
I II 
8.19 ±. 0.36 7. 77 ±. 1.64 
IIJ:: 
7 .~82 ±/ 0 .33 
IV 
7.87 ±. 0.14 
2. Lowest value at peak anemia, RBC - x 106 cells per mm. 2 
I 
J.42 ±. 0 .56 
II 
2.06 ±. 0.32 
III 
1.79 ±. 0.51 
IV 
6.39 ±. 0.35 
3. Patent day lowest RBC count reached, days. 
I 
10.2 ±. 1. 6 
II 
11.2 ±. 1.3 
III 
10.8 ±. 1.9 
TABLE IX 
IV 
28.6 ±. 14~5 
:ME.AN CORPUSCULAR VOLUME COMPARISONS+ 
1. Prepatent "normal'' values, MCV - cubic microns, 
I 
37 .o ±. 1.3 
. II 
36.7 ±. 0.9 
III 
40.6 ±. 4,7 
IV 
J9.2 ±.2.1 
"F" 
0.81 
74 
"F" 
138.80** 
"F" 
9.oo** 
"F" 
2.82 
2. Highest value reached. during patent period, MVC - cubic microns. 
I 
64.3 ±. 5.7 
II 
70.3 ±. 6.2 
III 
74.6±7.8 
IV 
41.6 ± 2.1 
3. Patent day that highest MCV value was reached, days, 
I 
19.2 ± 3.3 
II 
14.7 ±. 4.1 
III 
12.8 ±. 1.0 
+ I - Primary disease response in the intact calf: n = 6. 
"F" 
32.31** 
"F" 
0.44 
II - Primary relapse in the splenectomized carrier calf: n = 6. 
III - Primary·di.sease in the splenectomized calf: n = 6. 
IV - Control laparotomy of carrier calf: n = 5. 
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Figure 43. Linear regression of the percentage of parasi-
tized erythrocytes on the percentage of erythrocytes lost 
during the a,nernic phase of the patent period of anaplas-
mosis in: Oroup I. - The primary disease response in the 
intact calf, N = 6, beta= -0.186; Group II - The .primary 
relapse in the splenectornized carrier calf, N = 6, beta= 
-0.612; Group III - The primary disease response in the 
splenectomized calf, N = 6, beta= ~0.467. The calcu-
lated values, of Student's 11 t 11 are: between betaI and 
betan = 24.45**; between betaI and betanI = 6 .. 39**; 
between betaII and betaIIl = 2 .• 94*. These regressions 
are calculated from data in Tables.l, 2, and J. Group 
IV was omitt.ed since it approximated zero. (Y-axis is 
expressed as the percentage of parasitized eryt;brocytes.) 
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TABLE X 
IvIBAN CORPUSCULAR HEMOGLOBIN CONCENTRATION COMPARISONS+ 
L Prepatent nnormal" values, MCHC - percent, 
I II III IV "F" 
28,6 ±. 1.2 32,5 ±. 2.1 JJ.7 ±. 0,6 32.0 ±. LO 15.65** 
2. Lowest MCHC value reached during the patent period, percent. 
I 
27 ,2 ±. L2 
II 
24,0 ±. 5.4 
III 
25.2 ±. 5.5 
IV 
29,6 ±. 5.6 
J, Patent day when lowest MCHC occurred, days, 
I 
17.8 ±. 2,9 
II 
11.8 ±. 1.9 
III 
10,J ±. 4,5 
TABLE XI 
IV 
23.6 ±. 12,4 
PERCENT PARASITIZED ERYTHROCYTES (PPE) COMPARISONS+ 
"F" 
L46 
"F" 
4,91* 
l, Highest PPE reached during the patent period; · '(Note changed order) 
IV 
00,0 
II 
JO, 7 ±. 7, 6 
2, Patent day that highest PPE was reached. 
I 
7,3 ±. LO 
II 
8,J ±. 2,0 
III 
8,2 ± 0,8 
III 
37 ,8 ±. 2L8 
IV 
00,0 
"Fff 
11.26** 
"F" 
57.95 ** 
J, Highest PPE reached during patent periodJ excluding data from two 
animals in Group III which died of anaplasmosis, (Order changed) 
+ I 
II 
III 
IV 
-
~ 
-
IV 
00,0 
Primary 
Primary 
Primary 
Control 
I 
12,8 ±. J.8 
III 
24,J ± 6,2 
disease response in the intact 
relapse in the splenectomized 
disease in the splenectomized 
laparotomy of carrier calf: n 
II 
JO, 7 ± 7, 6 
calf: n ~":; 6. 
carrier calf: 
calf: n - 6, 
·- 5' 
n 
ff Fii 
34,41** 
- 6, 
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TABLE XII 
NUMBER OF PARASITIZED ERTYHROCYTES (PRBC) COMP~RISONS+ 
1. Hi~hest PRBCcount reached during the patent period, cells x 
. 10 /rnm. 2 .. 
IV 
0.0 
.I II 
0.707 ±. 0.224 1.028 ±. 0.342 
III 
1.558 ±. 0.904 
"F" 
9.86** 
2. Patent day that highest PRBC count was re·ached. 
IV I 
0,0 6.3 ±. 1.5 
II 
6.8 ±. 0.8 
III 
6.2 ±. 1.2 
"F" 
45,77** 
J. Highest PRBC count reached during the patent period, excluding 
data from two animals in Group III which died of anaplasmosis. 
IV 
0.0 
I II III 
0.707 ±.,0.224 1.028 ±. 0,342 0.698 ±. 0.319 
"F" 
25.67** 
TABLE XIII 
COMPARISONS OF THE LENGTHS OF VARIOUS TIME PERIODS DURING THE DISEASE+ 
1. Length of the prepatent period; day of infection to day 11 0" in 
Groups I and III; day of splenectomy to day 11 011 in Group II. 
Group IV omitted since it showed no detected response. 
(Given in days) 
II I III "teal." between I 
10.7 ±. 1.9 30.0 ±. 2.7 29. 5 ±. 2 .8 and III= 0.31 
2. Length of time required to reach lowest POV after day rrorr, Vol, 
I II III IV "F" 
%. 
9.6 ±. 1.2 10.0 ±. 1. 6 9.8 ±. 1.7 29.6 ±. 8.9 28.00** 
J. Time required to return to 75 % of the prepatent POV after the 
anemic crisis. (Given in days) 
I 
16 .. 7 ±. 3 ,4 
II 
19.0 ±.1.7 
III 
20 .J ±. 1.6 
IV 
0.0 
+ I - Primary disease response in the intact calf: n = 6. 
"F" 
89.67** 
II - Primary relapse in the splenectomized carrier calf: n = 6. 
III - Primary disease response in the splenectomized calf: n = 6. 
IV - Control laparotomy of the carrier calf: n = 5. 
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TABLE XIV 
COMPLEMENT-FIXATION (CF) REACTIONS:THE COURSE OF THE EXPERINIENTS+ 
L Day of first positive CF reaction in the primary disease response. 
I 
- 6,.5 ±. L4 
III 
-0.8±.L8 
Calculated "t" 
6.02** 
2. Day that highest titer was reached, in the primary disease 
response. 
I 
+ 2.J ±. 2.9 
III 
+ 11.2 ±. 2.6 
Calculated "t" 
17.70** 
J. Highest CF titer reached in the primary disease response. 
Reported in the "standard" loglO mode. See Appendix - Fig. 44, 
I 
J.60 ±. 0.05 
III 
J.J6 ±. 0.04 
Calculated "t" 
4,89* 
4, Lowest CF titer reacb.ed in the primary relapse in the carrier 
calf. 
II 
0.48 ±. 0.75 
IV 
1.36 ±. O,JJ 
Calculated "t" 
8.26** 
5. Day that lowest CF titer was reached in the primary relapse. 
II 
+l,8±.7,l 
IV 
+ 42,l ±. 5.7 
Calculated "t" 
10,95** 
+ I - Primary disease response in the intact calf: n = 6. 
II - Primary relapse in the carrier calf: n"" 6. 
III Primary disease response in the splenectomiz:ed calf: n = 6, 
IV - Control laparotorny of the carrier calf: n = 5. 
L 
2. 
3, 
4, 
5. 
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TABLE XV 
COMPARISON OF HEMATOLOGICAL VALUES IN THE CALF ONE WEEK BEFORE AND 
SIX WEEKS AFTER SPLENECTOMY. GROUP V: . N ;:: 6. 
Prespleriectomy'. · . · Postspleriedtbmy. Calculated 
Values Values "t'1 Value"" 
Grams of hemoglobin per 100 ml. of blood. 
9,7 ±. LO 10.5 ±. 0.6 2,35 
Packed cell volumes percent of blood, 
31.l ±. 2.4 30.4 ±.- 1.2 0.79 
Numbers of erythrocytes per cubic millimeter of blood. 
8,29 ±. L36 10. 86 ±. 1. 71 7,34** 
Mean corpuscular volume in cubic microns. 
38,3 ±. 4,6 28.3 ±. 3.6 19,60** 
Mean corpuscular hemoglobin concentration in percentage, 
31.6 ±. 2,2 34,6 ±. 1.6 7,89** 
+ ''ti! :test 'dT.awn. from peired observations, N = 6, with 5 samples per 
observation per calf .. 
CHAPTER VII 
DlSCUSSION 
Mi.ale (66) and Greatorex (67) list the measurements of eryth-
rocyte count (RBC), hemoglobin content (HB), packed cell volume (PCV), 
mean corpuscular volume (MCV) and mean corpuscular hemoglobin concen-
tration (MCHC) as essential for the classification of the anemias. 
The writer has reported on these values, as well as those values 
indicating the degree of parasitern:i,a; Le., the percentage of para-
si tized erythrocytes (PPE) and the numbers of parasitized erythro-
cytes per cubic millimeter (PRBC). Complement-fixing titers (CF) 
were also measured because of their apparent relationship to the 
spleen and anaplasmosis (45 7 47). Values for several other tests 
were also recorded and will be reported separately. 
Pretreatment Normal Values 
The pretreatment "normal" mean values for all the tests and all 
the groups were rather uniform. Only the MCHC pretreatment mean for 
the intact calves of Group I appeared to be significantly different 
(P.05) from the other means. (See Table X, part 1). In the writer's 
experience with over 100 similar calves during a two year period in 
this section of Oklahoma, low MCHC values were not uncommon, even 
though the calves appeared to be on an adequate nutritional regime 
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and without apparent parasitic problems. 
However, even including the low MCHC for Group I, the values for 
all pretreatment means appeared to be within the normal limits listed 
for the calf by Schalm (68) and Greatorex (67). The values observed 
by the writer more closely agreed with those described by Greatorex. 
Many of the writer's normal means were in the lower edge of the 
normal limits given by Schalm. These differences were even more 
pronounced when one considers that Schalm's values were drawn from 
a primarily female population, and the writer's values were drawn 
from a mixed population. Since Schalm described the male as normally 
having higher blood values than the female, the writer's values were 
indeed lower than Schalm's normal data might indicate. 
Some of the greatest differences were observed in the RBC and 
MCV values and were probably due, in part, to technical differences 
and errors. Schalm (68) indicated that this type of error is co)I].IIlon 
and difficult to control. When standard deviations were inferred 
from the erythrocyte data given by Schalm, there appeared to be 
little difference in the variability of the two sets of data (69). 
Those differences, though small, tended to favor a smaller var-
iability in the writer's data. 
Effects of Splenectomy on the Uninfected Calf 
No changes were observed in HB or PCV values six weeks after 
splenectomy, There was an increase in MCHC and RBC values, and a 
marked decrease in MCV. (See Table XV). This could be interpreted 
as an increase of microcytic erythrocytes after splenectomy, Although 
anemia, siderocytosis, leptocytosis, Howell-Jolly bodies, poly-
cythemia, Heinz bodies, and other hematologic changes have been 
reported after splenectomy in other animals, few of these changes 
were observed in these calves (31). Only polycythemia and a reduced 
MCV were consistent features in the postsplenectomy state. Micro-
cytosis is consistent with leptocytosis, even though typical "targ(';t 
cells" were not definitely identified in the observed hematologic 
changes, 
H~matological Differences During the Prepatent Period 
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The only striking differences noted during this period were a 
marked rise in the RBC values by more than twenty percent during the 
late prepatent period ( the last two weeks before day ''0") and. a con-
current decrease in MCV values by fifteen to twenty percent for Groups 
I and III. Since the calculation of MCV values are dependent upon RBC 
values, such a concurrent" decrease might be expected, 
Upon inspection of Figures 36 and 37, it will be hoted that the 
shape and location (in time) of the REC and MCV.changes are distinctly 
different and appear to represent real changes. The fact that the PCV 
and HE values remained within normal limits suggests that this was a 
transient increase of microcytic erythrocytes. Transient prepatent 
increases in RBC values have been noted by other workers in anaplas-
mosis (70). Confirmation of this transient microcytosis awaits 
further cell..;.size distribution studies during the course of the 
disease using electronic sizing techniques, 
Hematologic Differences During the Early Patent Period 
Regardless of the prepatent response, as soon as the character-
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istic parasitemia develops, there was a marked fall in the values for 
HB, PCV, and RBC (days +2 through +8). The rate of fall was very 
similar for the intact and asplenic animals. (See Figures 34, 35 
and 36). Although the rate was similar, the peak anemia values were 
different for the various groups. The control laparotomy group 
showed no significant changes, and the intact animal became moder-
ately anemic. The two asplenic groups experienced severe, statis-
tically identical (P.05) anemias. (See part 2 of Tables VI, VII and 
VIII). 
The anemia values were lowest for Group III, suggesting that 
Group II did show some immunologic benefit from its previous exper-
ience with the acute anemia. This was supported by the fact that 
only Group III experienced death loss during this experiment (two of 
six animals died with anaplasmosis). This was also suggested by the 
calculations presented in Figure 43. When the percentage of eryth-
rocyte loss was compared with the degree of parasitemia, there were 
significant differences between all three groups. 
There are two mechanisms which might explain these differences. 
One is an increased sensitivity of the erythrocyte sequestering 
mechanism (20). The other is an increase in the number of circu-
lating cells susceptible to sequestration. Garnham (71) stated 
11
., •• removal of the spleen renders animals susceptible to malarial 
parasites which otherwise would be confined to the tissue stages .... 11 • 
Hematologic Differences During the Late Patent Period 
Asplenic Group III exhibited a marked persistent parasitemia, 
This is difficult to explain when one considers that the degree of 
anemia is similar in both asplenic groups.. .Again, it could be due 
to a persistent, though incomplete, acquired immunity (non-splenic 
in origin) in Group II. 
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In view of Wagner's (20) work, there is justification in assuming 
that there is some direct relationship between the circulating time 
of marginal-body carrying e.rythrocyte and the deg.ree of damage exper-
ienced by that erythrocyte. This could explain, in part, ·the higher 
degree and persistence of the parasitemia in asplenic calves. 
During the late patent period (up to day +50), only the RBC 
values for the intact animals returned to normal prepatent levels. 
Elevated HB and PCV values indicated an over compensation only in 
this group. The control group remained within normal limits . .A 
macrocytosis persisted in all three treatment groups.. .Asplenic Gro-qp 
III experienced a marked recrudescence· of the marginal. bodies which 
peaked out at day +48, .Asplenic Group II exhibited a very slight 
increase in circulating parasitized cells at day +35. 
Classification of the .Anemia 
The anemia of anaplasmosis in two year old steers has been 
described as normocytic norrnochromic changing to macrocytic hypo-
chromic after stimulation of erythropoiesis (1 ).. The writer observed 
a similar type of anemia in both asplenic groups of calves. However, 
the intact animals P while exhibiting. the macrocytic aspect, did not 
exhibit the hypbchromic aspect of the anemia. Even though the fitted 
curve graph- (Figure 38) shows a 'fhyperchromasia"-, this is an anomaly 
due to data transformat:i,on (see MCHC values, Table I) and the fact 
that the Group I pretreatment. mean for the MCHC value was signifi-
cantly lower than the other pretreatment means. If allowance is 
made for the low pr~treatrnent.mean, Group I still did not exhibit a 
significant hypochrornic phase during the course of .the anemia. This 
was consistent with other reports that the intact calf is the least 
susceptible of the bovine animals to .anapl.asmosis ( 6, 9, 72). Thus 
the anemia in the intact calf might be characterized as norrnocytic 
norrnochromic turning to macrocytic normochrornic (or only slightly 
hypochrornic). This illustrates the value and need for applying con-
current and integrated procedures to the study of the anemia of 
anaplasmosis (73), 
Differences in the Complement-Fixing Reaction 
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By the inspection of Figure 41 and Table XIV, there is noted a 
marked difference of the onset of the primary CF titer rise between 
the intact calves in Group I and the splenectomized calves in Group 
III. The intact calves responded some eight days earlier than the 
asplenic group. This response' was consistent with reports by Roby 
(72) and Murphy (4) on individual calves. (See Appendix Figure 45 and 
46) . .After splenectomy of the carrier calves, .there was a marked drop 
in CF titer. In both asplenic groups the initiation of the titer or 
the start of its return to presplenectomy values was concurrent with 
the initiation of the progressive parasiternia. (See. Figures 40 and 
41). This would suggest that demonstrable numbers.of parasitized eryth-
rocytes were necessary for the initiation of "non-splenic" antibody pro-
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duction. If one equates a demonstrable parasiternia with a large dose 
of foreign protein given intravenously, then it is possible to draw 
a close analogy between the CF response in the asplenic calf and the 
circulating antibody formation capabilities of the splenectomized 
rabbit (49); i.e., both appear to require very strong antigenic 
stimuli when given intravenously in the asplenic state for the pro-
duction of antibodies by non-splenic sources. Rowley's (49) work 
suggests that a significant amount of the non-splenic antibody pro-
duction is in the liver and visceral lymph nodes. 
Summary and Conclusions 
The degree and severity of the anemia of anaplasmosis in the 
calf is related to splenic function and previous immunologic exper-
ience. The intact calf does not appear to experience the severe hypo-
chromic phase of the anemia described for older animals. The persis-
tant CF antibody in the intact calf is produced primarily in the 
spleen. The initiation of CF antibody production by non-splenic 
sources in the calf apparently requires a large antigenic dose, In 
the intact calf and the splenectomized calfJ there is a transient 
rnicrocytic erythrocytosis immediately preceding the primary parasi-
temia, 
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Figure 44, Relationship of turbidity to the degree of 
hemolysis: An .example of the conversion chart used 
in the photonephelometric determination of complement-
fixation reacti.ons used at the Veterinary Research 
Laboratories, Pawhuska Division , College of Veteri-
nary Medicine, Oklahoma State University, Stillwater, 
Oklahoma. From this chart the reactions are then 
subjected to a log10 transformati on on the following 
basis: 4 + = 1.00 at 1/10; LJO at 1/20 ; 1.6 at 1/40; 
1.9 at 1/80; 2.2 at 1/160; 2.5 at 1/320; 2.8 at 1/640; 
J.1 at 1/1,280; J,4 at 1/2,560; J.7 at 1/5,120; and · 
4,.0 at 1/10,240 . The log transformation facilitates 
data handling for statistical purposes . 
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Fi gure 45, Cal f 1049, 6 month old s t eer with i n-
tact spleen, i nfected with Anaplasma marginale 
(California isolate ). Taken from Physical Het-
erogeneity of Bovine Gamma Gl obulins ; Response 
to Experimental Anaplasma Marginale Inf ection 
by Frederick A. Murphy, Jr., Ph.D., Disserta-
tion, University of California, 1964. Used by 
special permission of t he author. (4 ) . 
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Figure 46. Calf 84 E, 6 month old Jersey steer sple-
nectomized 3 days prior to infection with Anapl asma 
marginale (Florida i solate ). Taken from Physical 
Heterogeneity of Bovine Gamma Globulins; Response 
to Experimental Anaplasrna .Marginale Infection by 
Frederick A. Murphy, Jr., Dissertation, University 
of California, 1964 . Used by special permission of 
the author. (4). 
95 
84 E 
.. 
I 
.. 
D 
I jll II a 
· I I iii Ii i ,;i 
::! 
~ a 
g 
I 
PERCENT OF EFFLUENT 
Figure 47. DEAE Sephadex chromatography of sera of 
sera A - E from calf .84 E. Taken from Murphy (4) 
with the authorrs permission, 
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Abbreviations used by Murphy (4): 
PCV - Packed cell volume. 
CF Complement-fixation titer. 
PPE Percent parasitized 
erythrocytes, 
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Figure 48. DEAE Sephadex chroma-
tography of sera F - H from calf 
84 E. Taken from Murphy (4) with 
the author's permission. PERCENT OF EFFLUENT 
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Figure 49, -Deviations of the complement-fixation reactions 
during the prepatent and patent periods of anaplasmosis 
in Special Group I - The primary disease response in the 
:intact calf: N = 12, (Y-'ax:is is expressed as the log-
arytbm to the base 10 of the denominator of the highest 
di.luation giving a 4 + reaction, ) The wide bars indicate 
thgtthe, reactionp•were summed for successive two day 
periods, Drawn from unpublished data of E.W. Jones -
Used by permission, 
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Figure 50. Deviations of the complement-fixation reaction 
during the prepatent and patent periods of anaplasmosis 
in Special Group 2 - The primary disease response in the 
calf when spl.enectomized during the initial days of the 
patent period: N = J. (Y-axis is expressed as the log-
arythm to the base 10 of the denominator of the highest 
dilution giving a 4 + reaction.) Drawn from unpublished 
data of E.W. Jones Used by permission, 
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Figure 5L · Comparison of the complement-fixation reactions 
during the prepat.ent . arid patent peri ods of anaplasmosis 
between Speciai Group I arid Special. Group .II _ A·= Area 
representing the difference between the intact calf res-
ponse and the response. of the .calf splenectomized in the 
initial part of. the patent period,. B = Area representing 
the difference of the two special groups prior to splen-
ectomy. C = Area representing those calves which were 
splenectomized in the initial part of the patent period . 
Each arrow irtaicates . the splenect.Oiey"- of an individual 
calf. (Y-axis is expressed as the logari~hm to the base 
10 of the deng~nator of the highest dilution giving a 
4 + reaction.) Drawn fro~ unpublished ~ata of E.W.,,. Jones 
Used by permission. . . 
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